Natco Pharma Indi a leading company for the launch of various different generic medicines. As per the recent developments, the company has made an announcement regarding the launch of the first generic form of VELPANAT Velpatasvir 100mg and Sofosbuvir 400mg for the cure of Hepatitis C.
The VELPANAT is the generic version of US company Gilead Sciences new drug is called Epclusa.. The generic Epclusa or VELPANAT is helpful for treatment of all Hepatitis C adults that are suffering from genotype 1-6 chronic hepatitis C virus.
Natco recently signed a non-exclusive licensing agreement with Gilead Sciences in order to manufacture and sell VELPANAT, a generic chronic hepatitis C drugs in 101 developing nations. This is in the fixed-dose combination for the patients who are suffering from the chronic Hepatitis C.Find Velpanat Tablets Having Velpatasvir & Sofosbuvir #medsdelta Offers Generic Epclusa Tablets Wholesale Price Find Natco Velpanat MRP, Launch date , Images ,
http://bit.ly/2t6Xw6i

Advertisements